AAAAAA

   
Results: 1-9 |
Results: 9
Rational design, synthesis, and biological evaluation of rigid pyrrolidoneanalogues as potential inhibitors of prostate cancer cell growth
Authors: Qiao, LX Zhao, LY Rong, SB Wu, XW Wang, SM Fujii, T Kazanietz, MG Rauser, L Savage, J Roth, BL Flippen-Anderson, J Kozikowski, AP
Citation: Lx. Qiao et al., Rational design, synthesis, and biological evaluation of rigid pyrrolidoneanalogues as potential inhibitors of prostate cancer cell growth, BIOORG MED, 11(8), 2001, pp. 955-959
Synthesis of a hybrid analog of the acetylcholinesterase inhibitors huperzine A and huperzine B
Authors: Rajendran, V Rong, SB Saxena, A Doctor, BP Kozikowski, AP
Citation: V. Rajendran et al., Synthesis of a hybrid analog of the acetylcholinesterase inhibitors huperzine A and huperzine B, TETRAHEDR L, 42(32), 2001, pp. 5359-5361
Molecular modeling studies of the Akt PH domain and its interaction with phosphoinositides
Authors: Rong, SB Hu, YH Enyedy, I Powis, G Meuillet, EJ Wu, XW Wang, RX Wang, SM Kozikowski, AP
Citation: Sb. Rong et al., Molecular modeling studies of the Akt PH domain and its interaction with phosphoinositides, J MED CHEM, 44(6), 2001, pp. 898-908
Structural basis of bloom syndrome (BS) causing mutations in the BLM helicase domain
Authors: Rong, SB Valiaho, J Vihinen, M
Citation: Sb. Rong et al., Structural basis of bloom syndrome (BS) causing mutations in the BLM helicase domain, MOL MED, 6(3), 2000, pp. 155-164
Structural basis of Wiskott-Aldrich syndrome causing mutations in the WH1 domain
Authors: Rong, SB Vihinen, M
Citation: Sb. Rong et M. Vihinen, Structural basis of Wiskott-Aldrich syndrome causing mutations in the WH1 domain, J MOL MED-J, 78(9), 2000, pp. 530-537
Molecular modeling on solvent effect and interaction mechanism of fentanylanalogs to mu-opioid receptor
Authors: Huang, XQ Jiang, HL Luo, XM Rong, SB Gu, JD Tan, XJ Zhu, YC Chen, KX Ji, RY
Citation: Xq. Huang et al., Molecular modeling on solvent effect and interaction mechanism of fentanylanalogs to mu-opioid receptor, ACT PHAR SI, 21(1), 2000, pp. 46-54
The synthesis of substituted (4S)-4-(hydroxymethyl)imidazolidin-2-one as novel protein kinase C modulators
Authors: Zhao, LY Qiao, LX Rong, SB Kozikowski, AP
Citation: Ly. Zhao et al., The synthesis of substituted (4S)-4-(hydroxymethyl)imidazolidin-2-one as novel protein kinase C modulators, TETRAHEDR L, 41(45), 2000, pp. 8711-8715
3-(Hydroxymethyl)-bearing phosphatidylinositol ether lipid analogues and carbonate surrogates block PI3-K, Akt, and cancer cell growth
Authors: Hu, YH Qiao, LX Wang, SM Rong, SB Meuillet, EJ Berggren, M Gallegos, A Powis, G Kozikowski, AP
Citation: Yh. Hu et al., 3-(Hydroxymethyl)-bearing phosphatidylinositol ether lipid analogues and carbonate surrogates block PI3-K, Akt, and cancer cell growth, J MED CHEM, 43(16), 2000, pp. 3045-3051
Theoretical studies on opioid receptors and ligands. I. Molecular modelingand QSAR studies on the interaction mechanism of fentanyl analogs binding to mu-opioid receptor
Authors: Jiang, HL Huang, XQ Rong, SB Luo, XM Chen, JZ Tang, Y Chen, KX Zhu, YC Jin, WQ Chi, ZQ Ji, RY Cao, Y
Citation: Hl. Jiang et al., Theoretical studies on opioid receptors and ligands. I. Molecular modelingand QSAR studies on the interaction mechanism of fentanyl analogs binding to mu-opioid receptor, INT J QUANT, 78(4), 2000, pp. 285-293
Risultati: 1-9 |